Croatia
Czech Republic
Denmark
Finland
France
Germany
Hungary
Ireland
Italy
United States
Sylvain Darondel, Business Unit Manager BioPharma Stability Storage, Eurofins BioPharma Product Testing France
Hugo Magrin, Business Unit Manager BioPharma Chemistry, Eurofins BioPharma Product Testing France
Failing to maintain proper temperature and humidity levels can lead to product degradation, compromising study results, patient safety, and regulatory compliance.
Such deviations pose financial, reputational, and regulatory risks, including warning letters or loss of GMP certification.
A systematic approach aligned with GMP and ICH guidelines is critical. Equipment qualification processes (Design Qualification, IQ, OQ, PQ) should follow structured methodologies (e.g., V-diagram) to ensure performance under real operational conditions. Continuous monitoring, preventive and curative maintenance programs, and safety measures like backup generators and redundancy systems are essential.
Temperature and humidity probes must be carefully selected, calibrated, and positioned to ensure precise, representative measurements. Using 21 CFR Part 11-compliant software ensures data integrity through features like audit trails, electronic signatures, and secure backups.
Risk analysis is crucial to prepare for power outages, equipment failures, and monitoring interruptions. Strategies include qualified backup equipment, generators, and degraded mode procedures to maintain operations. For example, backup freezers or redundant systems in climate chambers prevent disruptions during failures.
Maintaining storage conditions depends on robust equipment qualification and maintenance, data integrity, and well-implemented contingency measures. These practices ensure regulatory compliance and protect the integrity of stored products.